Guildford's Ergomed confident in future growth prospects

Published by

Tom Kilkelly

iStock

Guildford based service provider to the pharmaceutical industry Ergomed expects growth to continue, despite industry headwinds, following its successful financial year in 2022.

This confidence has largely been inspired by new CFO of the company Jonathan Curtain, who joined in January 2023. Jonathan's experience in finance and investor relations, brought from his previous role as Senior Vice President of Finance at Icon PLC, has helped him oversee the continued growth of the company.

Jonathan said: ''Overall we're very pleased with the continued progress that we made during 2022. We saw another strong year of revenue growth in both our CRO and Pharmacovigilance divisions. We're up 23 per cent at a group level, to a £145.3 million in line with our market expectations.

''This is all at a time when there have been wider industry and global macro economic headwinds.

''From an operational perspective we've completed our most recent acquisition, ADAMAS, in February last year which was integrated successfully. We also saw the largest market for our services, which is in the US, grow to make 62 per cent of our revenues and we will look to continue to invest in that area going forward.

''Finally, the strengthening of our board and management teams with the appointments of John Dawson, Anne Whitaker, and Michael Spiteri set us up for continued success going into the future.''

Tom Kilkelly

Tom Kilkelly started working as a freelance journalist for The Business Magazine following his graduation from UCL in 2022. During his studies Tom became very interested in the works of Irish authors including Samuel Beckett and Flann O'Brien (Brian O'Nolan). His current role as a freelance business reporter is his first exposure to the world of business journalism. Working at TBM has given Tom the chance to really get to grips with the goings-on in the business hive that is the South East.